The physiological stimulus to exocytosis in mast cells is the crosslinking of the high-affinity IgE receptor, FcεR1, with antigen. We demonstrate a novel function for ADP-ribosylation factor 1 (ARF1) in the regulation of antigen-stimulated secretion using cytosol-depleted RBL-2H3 mast cells for reconstitution of secretory responses. When antigen is used as the stimulus, ARF1 also reconstitutes phospholipase D activation. Using ethanol to divert the phosphatidic acid (the product of phospholipase D activity) to phosphatidylethanol causes inhibition of ARF1-reconstituted secretion. In addition. ARF1 causes an increase in phosphatidylinositol 4,5-bisphosphate (PIP # ) levels at the expense of phosphatidylinositol 4-monophosphate. The requirement for
INTRODUCTION
The physiological stimulus to exocytosis in mast cells is the crosslinking of the high-affinity IgE receptor, FcεR1, by antigen [1] . Upon stimulation, multiple signalling pathways are triggered, including the activation of phosphoinositide 3-kinase, phospholipase Cγ (PLCγ) and phospholipase D (PLD). PLCγ hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP # ) to generate the second messengers inositol 1,4,5-trisphosphate and diacylglycerol. Inositol 1,4,5-trisphosphate mobilizes intracellular Ca# + , whereas diacylglycerol mediates the activation of protein kinase C isoenzymes. Both Ca# + and protein kinase C have been implicated in the control of the exocytotic machinery by undefined mechanisms [2] . Likewise wortmannin, an inhibitor of phosphoinositide 3-kinase, also inhibits antigen-mediated exocytosis. The potential role of PLD in regulated exocytosis is indicated by the observation that ethanol can inhibit antigenmediated exocytosis from mast cells [3] .
Studies of exocytosis from cells of haematopoietic origin, including mast cells, have indicated an essential role for a Gprotein (G E ) in addition to increases in Ca# + [4, 5] . Subsequent work has revealed several candidate G-proteins that are involved in exocytosis. These include the Rho family members Rac and Rho [6] [7] [8] , and the heterotrimeric G-protein G i$ [9] . The constitutively active mutant proteins V14RhoA and V12Rac1 enhanced Ca# + -regulated exocytosis from permeabilized mast cells by increasing the proportion of cells that were competent to respond to stimulation. In addition, inhibition of endogenous Rac and Rho activity using inhibitors (N17Rac1 and C3 transAbbreviations used : ARF, ADP-ribosylation factor ; PLD, phospholipase D ; PEt, phosphatidylethanol ; PC, phosphatidylcholine ; COP, coat protomer ; PA, phosphatidic acid ; PITP, phosphatidylinositol transfer protein ; PLC, phospholipase C, GTP [S] , guanosine 5h-[γ-thio]triphosphate ; ATP [S] , adenosine 5h-[γ-thio]triphosphate ; SLO, streptolysin O ; DNP-HSA, dinitrophenol conjugated to human serum albumin ; PIP, phosphatidylinositol 4-monophosphate ; PIP 2 , phosphatidylinositol 4,5-bisphosphate. 1 To whom correspondence should be addressed (e-mail ucgbsxc!ucl.ac.uk).
PIP # in exocytosis was confirmed by using phosphatidylinositol transfer protein (PITPα) to increase PIP # levels. Exocytosis, restored by either ARF1 or PITPα, was inhibited when PIP # levels were depleted by phospholipase Cδ1. We conclude that the function of ARF1 and PITPα is to increase the local synthesis of PIP # , the function of which in exocytosis is likely to be linked to lipid-protein interactions, whereby recruitment of key components of the exocytotic machinery are targeted to the appropriate membrane compartment.
Key words : ARF1, phosphatidylinositol transfer protein, phospholipase Cδ, streptolysin O permeabilization.
ferase respectively) reduced the exocytotic response of mast cells to guanosine 5h-[γ-thio]triphosphate (GTP[S]) [6] . The effects on exocytosis were independent of changes on the cytoskeleton [7] . Independent studies using a different approach also identified Rac as an effector of exocytosis from these cells [8] . In none of these reports has the downstream component regulated by these G-proteins been identified.
PLD is activated by many cell surface receptors, including the cross-linking of the IgE receptor [10] . PLD catalyses the hydrolysis of phosphatidylcholine (PC) to phosphatidic acid (PA) and choline. In the presence of ethanol, PA is diverted to phosphatidylethanol (PEt), in a reaction known as transphosphatidylation. Reconstitution studies using cytosol and permeabilized HL60 cells or membranes initially identified ARF1 and ARF3 as regulators of mammalian PLD [11, 12] . Subsequent work has shown that all ARF proteins (ARF1-ARF6) are capable of activation. Two mammalian PLD enzymes (PLD1 and PLD2) have been cloned [13, 14] . Regulation of PLD1 has been intensively studied and is known to be directly and synergistically regulated by ARF1, Rho proteins (RhoA, Rac and Cdc42) and protein kinase Cα [15, 16] .
Rho protein and protein kinase C, direct regulators of PLD1 [15] , have already been identified as regulators of exocytosis from mast cells [7] . In the present study we have examined the requirement for ARF1 in antigen-stimulated exocytosis from cultured mast cells. We provide evidence that the function of ARF1 (via PLD) is to make PIP # available at localized membrane sites, which subsequently participate in the exocytotic pathway of mast cells. 
Figure 1 Time-dependent loss of exocytotic competence and PLD activation from permeabilized cells stimulated with GTP[S] (a, b) or with antigen (c, d)

MATERIAL AND METHODS
Materials
The nucleotides GTP[S], adenosine 5h-[γ-thio]triphosphate (ATP [S] ) and ATP were purchased from Boehringer Mannheim (Mannheim, Germany). Streptolysin O (SLO) was obtained from Murex (Dartford, U.K.) (MR16). IgE [anti-dinitrophenol (DNP)] and DNP conjugated to human serum albumin (DNP-HSA) (antigen) were purchased from Sigma. Monoclonal antibodies to phosphatidylinositol transfer protein α (PITPα) and ARF1 were prepared as detailed [17, 18] , and the polyclonal antibody to RhoA was purchased from Santa Cruz Biotechnology. Myristoylated ARF1 (referred to in the text as ARF1) and the myristoylated ARF1 mutant (N52R)ARF1 [referred to in the text as (N52R)ARF1] were expressed in Escherichia coli and purified exactly as described in [11] . Myristoylation was approximately 10 %. PITPα was expressed in E. coli and purified as described previously [19] .
Culturing and labelling of RBL-2H3 mast cells
Rat basophilic leukemic cells, RBL-2H3 mast cells, were grown in Dulbecco's modified minimal medium supplemented with 12.5 % (v\v) fetal calf serum, 4 mM glutamine, 50 µg\ml penicillin and 50 units\ml streptomycin. The cells were grown as a monolayer in 175 cm# vented flasks, at 37 mC with 5 % CO # and 100 % humidity. Each flask contains approx. 4i10( cells when confluent. For measurement of PLD activity, two protocols were used [20, 21] . RBL-2H3 mast cells were prelabelled with [$H]choline to label the PC pool. The label (0.5 µCi\ml) was added directly to the complete medium and the cells were allowed to proliferate for 48 h to reach 80 % confluence [21] . For measurements of PEt production, the cells were prelabelled with [$H]alkyl-lyso-PC (5 µCi\ml) in 2 ml for 1 h [20] . For the labelling of the inositol lipids, the cells were grown in the presence of [$H]inositol (1.0 µCi\ml) for 48 h.
Assays using permeabilized cells
Cell monolayers were washed twice in Dulbecco's modified minimal medium and scraped into 5 ml of fresh medium. IgE (2 µg\ml final) was added to sensitize the cells for 1 h at 37 mC. The cells were centrifuged at 450 g for 5 min at room temperature and resuspended in Hepes buffer, pH 7.2 (for antigen stimulation), or Pipes buffer, pH 6. supernatant was sampled to assay for released β-hexosaminidase [19] . To monitor the activation of PLD, [$H]choline-labelled cells were used, and release of [$H]choline was monitored as described previously [19] . This protocol is referred to as using ' acutely permeabilized ' cells.
To monitor the loss of exocytotic function and the ability to activate PLD as a function of permeabilization, 4 ml of cells (10(\ml) was added to 1 ml of permeabilization mixture containing 1 mM MgATP, 0.4 unit\ml SLO and 10 µM calcium buffered by 0.3 mM EGTA. Immediately, an aliquot of cells was transferred to assay tubes containing the appropriate stimulus at 37 mC to provide a starting point for the ' run-down '. The remaining cells were left to permeabilize at 37 mC. At timed intervals, further aliquots were removed and transferred to assay tubes. The final concentrations of the reagents in the final assay were 1 mM MgATP, 0.4 unit\ml SLO and 10 µM calcium buffered by 3 mM EGTA, plus GTP[S] (10 µM) or antigen (40 ng\ml). All assay tubes were incubated for 25 min at 37 mC, and reactions were terminated by centrifugation at 4 mC (1800 g for 5 min) ; 50 µl of the supernatant was sampled to assay for released β-hexosaminidase and for release of labelled choline.
Reconstitution of cytosol-depleted cells
Portions of 4 ml of cells (10(\ml) were added to 1 ml of permeabilization buffer as described above, and aliquots were removed immediately to measure the ' acutely permeabilized ' response. The remaining cells were transferred to 37 mC and allowed to permeabilize, for 5 min for reconstitution with antigen or for 10 min for reconstitution with GTP[S]. After permeabilization, the cells were pelleted by centrifugation (1800 g for 5 min) and the supernatant discarded. The cells were resuspended in buffer, and then aliquots were added to assay tubes containing the appropriate reagents, including ARF1 and PITPα, as indicated in the Figure legends PEt was analysed by TLC exactly as described previously [20] .
Leakage of ARF, Rho and PITPα from permeabilized cells
Aliquots of 4 ml of cells (5i10( cells) were added to 1 ml of permeabilization buffer, to give final concentrations of 1 mM MgATP, 0.4 unit\ml SLO and 100 nM Ca# + buffered by 0.3 mM EGTA. At the stated time points (5, 10 and 30 min), 1 ml samples were removed. After centrifugation of the cells (1800 g for 5 min), the supernatant was harvested and treated with 10 % trichloroacetic acid at 4 mC for 30 min to precipitate proteins. The precipitate was recovered by centrifugation (15 000 g for 15 min), resuspended in 50 µl of 1 M NaOH, and neutralized with 50 µl of 1 M Tris, pH 6.8. Precipitated proteins were separated by SDS\PAGE (14 % acrylamide), transferred to PVDF and Western-blotted with appropriate antibodies. The cell pellet was resuspended in 100 µl of RIPA buffer [150 mM NaCl, 1 % (v\v) Triton X-100, 0.5 % (w\v) deoxycholate, 0.1 % (w\v) SDS and 50 mM Tris, pH 7.5], vortexed thoroughly and placed at 4 mC for 30 min. After centrifugation at 15 000 g for 15 min at 4 mC, the solubilized proteins were concentrated by treatment with trichloroacetic acid as described above.
Changes in localization of PITPα and ARF after stimulation with antigen
Intact RBL-2H3 mast cells were stimulated with antigen for 10 min at 37 mC. Cells were permeabilized with SLO for a further 10 min, and cell pellets and the leaked cytosol were separated by centrifugation (1800 g for 5 min). The presence of PITPα and ARF in the cell pellet compared with the cytosol was probed by Western blotting as described above.
Measurement of polyphosphoinositide levels in permeabilized cells
Aliquots of 4 ml of RBL-2H3 mast cells were permeabilized for 10 min to deplete the cells of cytosolic proteins and washed as described above. The cytosol-depleted cells were resuspended in buffer containing 1 mM MgATP and 10 µM Ca# + . Next 20 µCi\ml [γ-$#P]ATP was added to the cells, aliquots of which which were immediately added to assay tubes containing the stimulus and proteins as indicated in the Figure legends. The cells (100 µl final) were incubated at 37 mC for 20 min, transferred to 4 mC and quenched with 375 µl of acidified chloroform\ methanol\conc. HCl (100 : 200 : 1.5, by vol.), and the mixture was vortexed thoroughly to obtain a single phase. Then 10 µl of Folch extract was added [Folch extract (Sigma) is a brain lipid extract rich in phosphoinositides added to aid recovery of labelled phosphoinositides]. Next, 125 µl each of chloroform and 0.1 M HCl were added to obtain two phases. The samples were vortexed thoroughly and then centrifuged (1800 g for 5 min). The upper phase was removed and replaced with a ' synthetic ' upper phase of chloroform\methanol\0.1 M HCl (1 : 1 : 0.9, by vol.). The upper phase was replaced twice more, to remove the majority of the [$#P]ATP not incorporated into lipid. Finally, all of the chloroform phase was transferred to a clean Eppendorf tube, dried under vacuum and resuspended in 50 µl of chloroform. The polyphosphoinositides were separated by TLC as described previously [22] . The labelled lipids were analysed using a Fuji Phosphorimager, and the images were quantified using appropriate software.
Studies with rat peritoneal mast cells
Mast cells were obtained and purified exactly as described previously [5] . The protocol for cytosol depletion was identical to that used for RBL-2H3 cells described above.
RESULTS
Loss of secretory function and PLD activation from permeabilized cells
Stimulation of exocytosis from intact RBL-2H3 mast cells by antigen is inhibited by ethanol, implying a role for PLD in the signalling pathway leading to secretion. PLD activity is regulated by the small GTPases ARF1 and Rho proteins ; thus antigen stimulation can be bypassed by using GTP[S] as a stimulus in permeabilized cells. We initially established that both antigen and GTP[S] were capable of stimulating exocytosis and PLD activation in the permeabilized cells. We routinely used Pipes buffers, pH 6.8, for our experiments and found that secretion from antigen-stimulated cells was not well maintained in permeabilized cells. After experimenting with different conditions, we finally succeeded in identifying conditions that maintained antigen stimulation in permeabilized cells. This required working at pH 7.2.
We characterized the ability of the two stimuli, i.e. antigen and GTP [S] , to elicit secretion and PLD activation with respect to MgATP requirements and Ca# + requirements under conditions where the cytosolic proteins were still present. When the permeabilizing agent (SLO) and the stimulus were added simultaneously, both stimuli were capable of eliciting exocytosis optimally at 10 µM Ca# + in the presence of MgATP (Figure 1,  time 0) . We refer to this condition as ' acutely permeabilized '. The response to both stimuli was concentration-dependent ; near-maximal activation was observed with 1 µM GTP[S] and maximal activation at 10 µM. For antigen, maximal secretion occurred at 40 ng\ml. Secretion was found to plateau at 20-25 min for both stimuli. In all subsequent experiments, GTP[S] was used at 10 µM and antigen at 40 ng\ml, and the cells were stimulated for 25 min.
Permeabilization with SLO generates lesions, which allow freely diffusable proteins to exit from cells. To examine the role of cytosolic proteins in secretion and PLD activation, the cells were permeabilized for different lengths of time to deplete cytosolic proteins. Antigen or GTP[S] was added subsequently (Figure 1) . Parallel declines in PLD activity and exocytosis were 32 P]ATP in the presence or absence of 100 µg/ml ARF1 at 10 µM Ca 2 + , or with (b) 20 µCi/ml [γ-32 P]ATP in the presence or absence of 50 µg/ml PITPα at 10 µM Ca 2 + . The reactions were incubated at 37 mC for 20 min, quenched with chloroform/methanol and the polyphosphoinositides extracted and analysed by TLC. The TLC plates were analysed using a PhosphorImager plate, and the images of the plate are shown in the lower panels. The data were quantified using the appropriate software and are expressed as arbitrary units of image intensity (PSL). All experiments were conducted in duplicate and were repeated on four separate occasions with similar results. Error bars reflect the ranges of the duplicate values.
Figure 5 Ethanol inhibits ARF1-reconstituted exocytosis and increases PEt production
Figure 7 PITPα and ARF1 restore exocytosis
RBL-2H3 mast cells were depleted of cytosol, and reconstituted with 50 µg/ml PITPα, ARF1 or both in the presence or absence of (A) 10 µM GTP[S] or (B) antigen (40 ng/ml). The reactions were incubated for 25 min at 37 mC, and after centrifugation the supernatants were analysed for released β-hexosaminidase. Values are meanspS.E.M. from four experiments. The difference between secretion elicited by ARF1 alone or PITPα alone and that elicited by a combination of ARF1 and PITPα was analysed by a two-tailed t test, and these values were significantly different (P 0.02). A.P. denotes ' acutely permeabilized ' cells (see the text for details). To determine whether the loss of ARF1 proteins contributed to the decline in secretory and PLD responses, the leaked supernatant from the permeabilized cell preparations was examined (Figure 2 ). Within 5-10 min a substantial proportion of ARF1 proteins was found in the supernatant. In contrast, Rho proteins did not substantially leak out of cells, similar to results obtain previously with human neutrophils [16] .
Secretion and PLD activation can be restored by ARF1 proteins in cytosol-depleted cells
To examine the possibility that ARF1 could restore the loss of secretory function and PLD activation from the cytosol-depleted cells, a reconstitution assay was used. For GTP[S] as a stimulus, the cells were permeabilized for 10 min and then washed by centrifugation to remove the leaked proteins. The depleted cells were stimulated with GTP[S] in the presence or absence of ARF1 or an ARF1 mutant, (N52R)ARF1, which can bind GTP but is unable to activate PLD1 [23] (Figure 3a) . ARF1, but not (N52R)ARF1, increased both secretion and PLD activation in the cytosol-depleted cells. Optimal restoration of both responses required the presence of MgATP and 10 µM Ca# + . To confirm that reconstitution of PLD activity and secretion was dependent on the activation of ARF1 by a guanine nucleotide, ATP[S] was examined ; this nucleotide was not able to support ARF1-reconstituted exocytosis or PLD activity (Figures 3a and 3b) .
The above experiment indicated that ARF1 could potentially mediate the activation of PLD and secretion, but did not reveal whether ARF1 is a component of the secretory pathway when a physiological stimulus is applied. To explore this possibility, RBL-2H3 mast cells were permeabilized for 5 min, washed and washed and stimulated with antigen (40 ng/ml) in the presence or absence of 10 µg/ml PLCδ1, 100 µg/ml ARF1 or 50 µg/ml PITPα for 25 min at 37 mC. The supernatants were analysed for released β-hexosaminidase or for released inositol phosphates (IPs), derived from hydrolysis of phosphoinositides by PLCδ1. The lipids were extracted from the cells and the levels of PIP 2 were analysed by TLC. Values are meansprange of duplicate incubations, and are taken from one of three similar experiments.
subsequently stimulated with antigen in the presence or absence of myristoylated ARF1 or the mutant (N52R)ARF1. Figure 4 illustrates that loss of secretory response to antigen was regained when ARF1 was included in the assay. Restoration was optimal at 10 µM Ca# + . We noted that secretion stimulated by the antigen could only be restored provided that the permeabilization interval did not exceed 6-8 min. Restoration of the secretory process was strictly MgATP-dependent, emphasizing a requirement for phosphorylation. Specificity was tested using the inactive ARF1
Figure 9 Antigen stimulation results in the retardation of PITPα and ARF1 leakage from permeabilized RBL-2H3 mast cells
Intact RBL-2H3 mast cells were stimulated with antigen (40 ng/ml DNP-HSA) for 10 min, and subsequently permeabilized with 0.4 unit/ml SLO for 10 min. Cellular membranes (Mem.) were separated from their leaked cytosolic contents (Cyt.) and analysed by Western blotting for ARF1 and PITPα. For the positive controls, recombinant proteins were used. mutant (N52R)ARF1. PLD activity and secretion were restored in parallel by ARF1, but not by (N52R)ARF1 (Figures 4b and  4c ).
How does ARF1 restore secretory function ?
A potential mechanism underlying the effects of ARF1 on secretion could be linked to its ability to stimulate PLD. Our recent analysis using ARF mutants identified a good correspondence between the ability of ARF1 to stimulate PLD activity and secretion in HL60 cells [23] . On the assumption that it is the production of PA that is required for secretory function, we used ethanol to divert the PA into production of PEt, in order to provide supporting evidence that PLD activation is required for the secretory process. Restoration of secretory function by ARF1jGTP[S] or by ARF1jantigen was inhibited by ethanol in a concentration-dependent manner (Figures 5a and 5b) . Likewise, in the presence of increasing concentrations of ethanol, PEt production increased (Figures 5c and 5d ). Ethanol at 1 % (v\v) was sufficient to inhibit secretion mediated by antigenjARF1 in the reconstituted system ; this concentration effectively inhibits secretion in intact cells [3, 24] . In contrast, 3 % ethanol was required for inhibition of secretion mediated by GTP[S]jARF1 in the reconstituted system (compare Figures 5a  and 5b) . This difference in sensitivity to ethanol could reflect the lower levels of PLD activation stimulated by antigenjARF1 compared with GTP[S]jARF1. When GTP[S]jARF1 is used as a stimulus, ethanol is less effective because of the greater potency of GTP[S] as a stimulus (compare Figures 5c and 5d) .
We next examined whether ARF1 has an effect on phosphoinositide levels. ARF1 has been shown to raise PIP # levels via direct activation of phosphoinositide 4-kinase β [25] . Alternatively, ARF1 raises PA levels via PLD, and PA can potentially activate type I phosphatidylinositol monophosphate 5-kinase, which catalyses the phosphorylation of phosphatidylinositol 4-monophosphate (PIP) to PIP # [26] [27] [28] . Figure 6 (a) illustrates that ARF1 increased PIP # levels in permeabilized cells, and this was accompanied by a decrease in PIP levels. The increase in PIP # levels was small, but may only appear so because we are monitoring global cellular levels of PIP # , which include multiple pools which may not be affected by ARF1. Because of the small changes, we have been unable to use ethanol to examine whether the increase in PIP # levels is mediated directly via ARF1 or via the ARF1-stimulated PLD pathway. However, to test the possibility that increased production of PIP # was the essential outcome of the effect of ARF1, we examined whether PITPα, another cytosolic protein that is known to be important in PIP # synthesis [22] , could replace ARF1 in the exocytotic process. PITPα was detected in RBL-2H3 mast cells by immunoblotting, and was found to leak out of SLO-permeabilized cells at a similar rate to ARF1 (Figure 2) .
PITPα was found to restore exocytosis ( Figures 7A and 7B ), but not PLD activity (results not shown). Unlike ARF1, addition of PITPα increased the levels of both PIP and PIP # in permeabilized RBL-2H3 mast cells (Figure 6b ). However, an increase in PIP # levels was insufficient to trigger exocytosis, as stimulation with GTP[S] or antigen was still required (see Figure  7) . The effect of PITPα on secretion was both Ca# + -and MgATPdependent. The combination of PITPα and ARF1 gave a slight enhancement over the effects of each component alone, and the level of secretion attained was similar to that obtained in the acutely permeabilized cells, where the endogenous proteins were still present (Figure 7) .
To reinforce the importance of PIP # in exocytosis, we used PLCδ1 to deplete PIP # levels. We confirmed that addition of PLCδ1 increased the production of inositol phosphates ( Figure  8b ). PLCδ1 reduced PIP # levels by nearly 40 % (Figure 8c ), and this was sufficient to inhibit both PITPα-and ARF1-reconstituted antigen-mediated exocytosis (Figure 8a ). When PITPα was present together with PLCδ1, inositol phosphate production was substantially enhanced ; this is an expected result, as the transfer protein is involved in regulating substrate supply [29] .
Antigen stimulation leads to recruitment of PITPα and ARF1 to membranes
Both ARF1 and PITPα have been found to reconstitute antigenmediated secretion. To examine whether both proteins can be regulated upon antigen-mediated stimulation, we examined the translocation of the two proteins from the cytosol to the membranes. Figure 9 illustrates that when cells were activated with antigen before permeabilization, less ARF1 and PITPα exited from the cells and became associated with the membranes.
ARF1 also reconstitutes secretion from rat peritoneal mast cells
Rat peritoneal mast cells have been widely used in studies of exocytosis, and we also examined whether ARF1 proteins were capable of restoring secretory function in these cells. Rat mast cells were stimulated with 10 µM Ca# + and 10 µM GTP[S] either during the initial permeabilization with SLO (' acutely permeabilized ') or after cytosol depletion for 10 min. Ca# + and GTP[S] enhanced secretion to a small extent from cytosoldepleted cells, and this was potentiated when ARF1 was included during the assay (Figure 10 ). The extent of reconstitution observed with ARF1 did not reach the level seen in acutely permeabilized cells, suggesting that other cytosolic factors may have become rate limiting.
DISCUSSION
ARF1 has a central role in constitutive membrane traffic, where it has been identified as a structural component for coat protomer (COP)-coated vesicles [30] . Additionally, ARF1 is required for recruitment of adaptor proteins AP1, AP2 and AP3 at both the plasma membrane and the trans-Golgi network [31] [32] [33] . Other roles for ARF1 include a requirement in vesicle formation at the trans-Golgi network in a reaction not necessarily requiring COPs or other identified coat proteins [34] , and recruitment of paxillin to focal adhesion complexes [35] . In the present study we extend the function of ARF1 to include a role in antigen-regulated exocytosis in RBL-2H3 mast cells.
ARF1 can interact directly with several effectors, including PLD1, ARFAPTIN and the β-subunit of coatomer proteins [15, 36, 37] . In the present study of regulated exocytosis, the data support the possibility that part of the function of ARF1 is mediated via PLD. Previous studies using intact mast cells have shown that ethanol (a reagent that interferes with the production of PA, the product of PLD activity) inhibits secretion [3, 24] . In the present study we demonstrate that the ability of ARF1 to reconstitute secretion was also inhibited by ethanol. Additional evidence that ARF1-mediated exocytosis is via PLD comes from mutational analysis of ARF1 ; PLD effector domain mutants have greatly extended the relationship between PLD activation and exocytosis [23] . Other activators of the exocytotic process that have been identified in mast cells are Rho proteins and protein kinase C [2, 6, 7] . Rho proteins are also recognized regulators of PLD activity, as are the conventional isoforms of protein kinase C [10, 15, 38] . Thus a common theme emerges : the proteins that have been identified previously as participants in the exocytotic function of RBL-2H3 mast cells are all activators of the PLD pathway.
We also show that ARF1 can stimulate PIP # synthesis at the expense of PIP in permeabilized cells. The mechanism of this stimulation may be complex. The product of ARF1-regulated PLD activity is PA, which can regulate the activity of type 1 PIP 5-kinases [26] [27] [28] . In addition, ARF1 has been shown to increase PIP and PIP # levels at the Golgi by recruitment of phosphoinositide and PIP kinase independently of PLD activity [39] . Although we cannot rule out this route of PIP # synthesis taking place at the Golgi, only PIP # produced at the lysosomal granule or the plasma membrane (or both) could play a role in exocytosis. PLD1 and ARF6 both localize at the lysosomes and plasma membranes, indicating that these are the relevant sites of PA production, and thus PIP # synthesis [40] [41] [42] . (Although we have used ARF1 for our studies, ARF6 is equally capable of restoring secretory function in permeabilized cells. Due to the instability of myristoylated ARF6, a detailed analysis has not been possible.) The ability of PITPα to replace ARF1 in the reconstitution assay provides further support for the hypothesis that PIP # is required for exocytosis. PITPα is also required for the synthesis of PIP # as a substrate for PLCs [22, 43] , in the Ca# + -stimulated exocytotic pathway in PC12 cells [44, 45] , and for vesicle formation ( [46] ; reviewed in [47] ). Interestingly, PITPα and ARF1 can be functionally exchanged in the vesicle formation assay, just as in the secretory reconstitution assays presented here.
ARF1 and PITPα both restore exocytosis from permeabilized RBL-2H3 mast cells by stimulating the synthesis of PIP # , and in their combined presence the response was more robust. This suggests that both proteins are physiologically relevant, and this is clearly supported by the observation that antigen stimulation causes the relocation of both proteins. Potential roles for PIP # in exocytosis include recruitment of specific proteins in a spatially and temporally regulated manner, and modulation of enzymic activities. There are many proteins with pleckstrin homolgy domains that interact with PIP # [48] . In addition, many cytoskeletal proteins undergo conformational changes in the presence of PIP # [49] . While the results presented here do not shed light on the mechanism of the PIP # requirement in exocytosis, they provide a clear indication that this lipid plays a prominent role in the process leading to exocytosis, not only in neuronal cells but also in cells of the haematopoietic origin.
